Oily, blemish-prone skin?
This one's for you.
Anti-Blemishes Concentrate not only helps to reduce the look of blemishes and blackheads from 7 days* but also limits their reappearance, thanks to its innovative formulation which includes exclusive ComedoclastinTM, a plant-based active ingredient derived from milk thistle oil. Designed to regulate the hyperproduction of sebum, the minimalist formula has an ultra-light, non-greasy texture that absorbs quickly with a soft matte finish, making it ideal for oily sensitive skin.
Key features and benefits of the Avene Cleanance Anti-Blemishes Concentrate
- CLINICALLY PROVEN to reduce blemishes by 45% after 8 weeks*
- anti-blemishes, anti-recurrence
- Very rich in Thermal Spring Water for its soothing, softening and anti-irritating properties
- Highly concentrated formula for targeted dual action
- Significantly reduces blemishes and blackheads from 7 days*
- Significantly refines pores appearance from 7 days*
- Regulates hyper-production of sebum for a matte finish
- Light, non-greasy fluid, quickly absorbed, specifically adapted for oily skin
- Paraben free, fragrance free
- Formulated to minimise the risk of allergic reaction, non-comedogenic
What are the key ingredients in the Avene Cleanance Anti-Blemishes Concentrate?
Avène-Thermal-Spring-Water
Clinically proven by 150 studies to soothe, soften and calm the skin.
Comedoclastin™
Helps to reduce the appearance of blemishes and limits their reappearance.
How to use the Avene Cleanance Anti-Blemishes Concentrate
Dispense 1 dose of Cleanance Comedomed on your fingertips.
• Start by dabbing it onto the T-zone and the cheeks.
• Use circular motions to boost penetration.
• Finish by smoothing on the cheeks and lower face.
Reapply morning and evening.
*Clinical assessment by dermatologist conducted on 51 subjects – Comedomed applied twice daily.
**Comparative study conducted on 36 subjects (aged 18-34) under dermatological control for 56 days. One untreated control group (N=18), one group treated twice a day with Cleanance Comedomed (N=18)